Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Mar 1, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how to reduce the chances of needing to put a breathing tube back in (reintubation) for patients who have just undergone heart surgery. The researchers want to compare two groups of patients: one group will receive oxygen therapy using high-flow nasal cannulas (which are soft tubes that deliver oxygen through the nose), while the other group will receive the usual care chosen by their healthcare team. The goal is to see which method leads to better outcomes after surgery.

To be eligible for this study, participants need to be adults aged 18 and older who have had heart surgery that lasted at least three hours and were on a breathing machine when they arrived at the intensive care unit. They also need to be expected to have their breathing tube removed at some point while in the unit. Those who meet these criteria will have the opportunity to help researchers understand how to improve care for heart surgery patients. Participants can expect to be monitored closely during their recovery and may experience different methods of receiving oxygen as part of the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 and over treated in the Vanderbilt Cardiovascular Intensive Care Unit following cardiac surgery (defined as surgery on the heart or thoracic aorta, excluding percutaneous procedures)
• • Surgical duration (anesthesia start to anesthesia stop) of at least 3 hours.
• • Intubated at the time of arrival in the Cardiovascular Intensive Care Unit
• • Extubated to occur at some point following arrival in the Cardiovascular Intensive Care Unit with an order to extubate the patient by a treating provider.
• Exclusion Criteria:
• • Does not meet inclusion criteria